Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic gets US clearance for Thera-i pacemakers:

This article was originally published in Clinica

Executive Summary

Medtronic has received FDA clearance for its Thera i-series pacemakers just in time to launch them at the American Heart Association meeting in Anaheim (November 11th-14th). The four i-series devices are about the same size as their Thera predecessors, but have greater longevity and have been re-shaped to make them easier to implant. At the top of the range, the dual chamber, rate-responsive, DR-i has improved automatic mode switching, to prevent inappropriate pacing during atrial flutter. The Thera series was approved in the US in January (see Clinica No 638, p 20) and the i-series was launched in Europe in July (see Clinica No 667, p 16).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094075

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel